Antiemesis Clinical Practice Guidelines in Oncology

被引：20

作者：

Ettinger, David S.

Armstrong, Debra K. ^{[1
]}

Barbour, Sally

Berger, Michael J. ^{[2
]}

Bierman, Philip J. ^{[3
]}

Bradbury, Bob

Ellis, Georgianna ^{[4
]}

Kirkegaard, Steve ^{[5
]}

Kloth, Dwight D.

Kris, Mark G. ^{[6
]}

Lim, Dean ^{[7
]}

Markiewicz, Michael Anne ^{[8
]}

Nabati, Lida

Nesheiwat, Carli ^{[9
]}

Rugo, Hope S. ^{[10
]}

Sorscher, Steven M. ^{[11
]}

Stucky-Marshal, Lisa ^{[12
]}

Todaro, Barbara

Urba, Susan ^{[13
]}

机构：

[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[2] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[3] Univ Nebraska Med Ctr, Eppley Canc Ctr, Lincoln, NE USA

[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA

[5] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[7] City Hope Comprehens Canc Ctr, Duarte, CA USA

[8] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA

[9] Univ Tennessee, Inst Canc, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[10] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[11] Washington Univ, Sch Med, St Louis, MO 63130 USA

[12] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[13] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2009年 / 7卷 / 05期

关键词：

NCCN Clinical Practice Guidelines; antiemesis; nausea and vomiting; chemotherapy-induced; 5-HT3-receptor antagonists; NK-1-receptor antagonists; CHEMOTHERAPY-INDUCED NAUSEA; HIGH-DOSE METOCLOPRAMIDE; MODERATELY EMETOGENIC CHEMOTHERAPY; CISPLATIN-INDUCED EMESIS; 5-HYDROXYTRYPTAMINE-3 RECEPTOR ANTAGONIST; ORAL NK1 ANTAGONIST; DOUBLE-BLIND; ANTICIPATORY NAUSEA; PHASE-III; DELAYED EMESIS;

D O I：

10.6004/jnccn.2009.0039

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：572 / 595

页数：24

相关论文

共 120 条

[41] Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity - an update [J].

Grunberg, SM ;

Osoba, D ;

Hesketh, PJ ;

Gralla, RJ ;

Borjeson, S ;

Rapoport, BL ;

du Bois, A ;

Tonato, M .

SUPPORTIVE CARE IN CANCER, 2005, 13 (02) :80-84

[42] Palonosetron:: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis [J].

Grunberg, SM ;

Koeller, JM .

EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (12) :2297-2303

[43] DOSE RANGING PHASE-I STUDY OF THE SEROTONIN ANTAGONIST GR38032F FOR PREVENTION OF CISPLATIN-INDUCED NAUSEA AND VOMITING [J].

GRUNBERG, SM ;

STEVENSON, LL ;

RUSSELL, CA ;

MCDERMED, JE .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :1137-1141

[44]

HARDING RK, 1993, EMESIS ANTICANCER TH, P163

[45] SUPERIORITY OF NABILONE OVER PROCHLORPERAZINE AS AN ANTI-EMETIC IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY [J].

HERMAN, TS ;

EINHORN, LH ;

JONES, SE ;

NAGY, C ;

CHESTER, AB ;

DEAN, JC ;

FURNAS, B ;

WILLIAMS, SD ;

LEIGH, SA ;

DORR, RT ;

MOON, TE .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (23) :1295-1297

[46] Randomized, double-blind trial comparing the antiemetic effect of tropisetron plus metopimazine with tropisetron plus placebo in patients receiving multiple cycles of multiple-day cisplatin-based chemotherapy [J].

Herrstedt, J. ;

Sigsgaard, T. C. ;

Nielsen, H. A. ;

Handberg, J. ;

Langer, S. W. ;

Ottesen, S. ;

Dombernowsky, P. .

SUPPORTIVE CARE IN CANCER, 2007, 15 (04) :417-426

[47] Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer [J].

Hesketh, P ;

Navari, R ;

Grote, T ;

Gralla, R ;

Hainsworth, J ;

Kris, M ;

Anthony, L ;

Khojasteh, A ;

Tapazoglou, E ;

Benedict, C ;

Hahne, W .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (08) :2242-2249

[48] The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin - The Aprepitant Protocol 052 Study Group [J].

Hesketh, PJ ;

Grunberg, SM ;

Gralla, RJ ;

Warr, DG ;

Roila, F ;

De Wit, R ;

Chawla, SP ;

Carides, AD ;

Ianus, J ;

Elmer, ME ;

Evans, JK ;

Beck, K ;

Reines, S ;

Horgan, KJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4112-4119

[49] SEROTONIN ANTAGONISTS - A NEW CLASS OF ANTIEMETIC AGENTS [J].

HESKETH, PJ ;

GANDARA, DR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (09) :613-620

[50] Proposal for classifying the acute emetogenicity of cancer chemotherapy [J].

Hesketh, PJ ;

Kris, MG ;

Grunberg, SM ;

Beck, T ;

Hainsworth, JD ;

Harker, G ;

Aapro, MS ;

Gandara, D ;

Lindley, CM .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :103-109

← 1 2 3 4 5 6 7 8 9 10 →